Education News and Research

RSS

Previous study has underestimated the true extent of racial disparities in COVID-19 deaths

More than a year into the pandemic, the disproportionate burden of COVID-19 among racial and ethnic minorities in the US has been well documented.

18 May 2021

Scientists develop experimental direct-acting antiviral therapy to treat COVID-19

An international team of scientists from the Menzies Health Institute Queensland (MHIQ) at Griffith University and from City of Hope, a research and treatment center for cancer, diabetes and other life-threatening diseases in the U.S., have developed an experimental direct-acting antiviral therapy to treat COVID-19.

18 May 2021

Study provides new basis to compare the effectiveness of different tuberculosis treatments

A new study published in Nature Communications provides an important new basis for comparing the effectiveness of different tuberculosis treatments.

18 May 2021

Charles Fracchia selected for DARPA ISAT Study Group

Dotmatics today announced that the US Defense Advanced Research Projects Agency has named Charles Fracchia to its ISAT Study Group.

18 May 2021

COVID-19 pandemic causes disproportionate rise in cardiovascular deaths among racial, ethnic minorities

In the early months of the COVID-19 pandemic, the United States experienced higher rates of heart disease and cerebrovascular disease deaths, relative to the corresponding months the previous year.

18 May 2021

Around half of U.S. parents unwilling to vaccinate their children against COVID-19

A national online survey in March 2021 found only 49.4% of parents living in the United States were planning to vaccinate their child. A parents’ vaccination status and level of vaccine hesitancy were associated with adolescent vaccinations against COVID-19.

18 May 2021

Study: No major difference in mortality between patients treated with drug-coated and non-drug-coated devices

Peripheral artery disease (PAD), or blockages in the arteries outside of the heart, affects more than 200 million people worldwide and 12.5 million people in the United States. Patients with this circulatory disorder may develop severe leg pain or unhealing wounds that require a minimally invasive revascularization procedure to open the blood vessels to improve blood flow.

18 May 2021

Type of heart failure may influence which approach is optimal for patients with AFib

Among patients with both heart failure and atrial fibrillation (AFib), treatment strategies focused on controlling the heart rhythm (using catheter ablation) and those focused on controlling the heart rate (using drugs and/or a pacemaker) showed no significant differences in terms of death from any cause or progression of heart failure.

18 May 2021

Sotagliflozin reduces adverse cardiovascular events across patients with diabetes, heart failure

Patients with both diabetes and heart failure who were treated with sotagliflozin, a novel investigational drug for diabetes, for a median of nine to 16 months experienced reductions of 22% to 43% in the risk of death or worsening heart failure compared with similar patients who were treated with a placebo

18 May 2021

Pirfenidone significantly reduces a marker of heart muscle scarring

Patients with heart failure with preserved ejection fraction who took the antifibrotic drug pirfenidone saw a significant reduction in a marker of heart muscle scarring compared with patients who received a placebo, based on findings from an early-phase trial presented at the American College of Cardiology's 70th Annual Scientific Session.

18 May 2021

Omecamtiv mecarbil significantly reduces hospitalizations among patients with severe heart failure

The experimental heart failure drug omecamtiv mecarbil reduced heart failure hospitalizations by a greater margin among patients with more severely reduced ejection fraction, a measure indicating severe impairment in the heart's pumping ability, compared with those who had moderately reduced ejection fraction, according to research presented at the American College of Cardiology's 70th Annual Scientific Session.

18 May 2021

Researchers receive $4.5 million grant to improve quality of care for people with cardiovascular disease

Researchers from the University of Tennessee Health Science Center have received a $4.5 million grant over three years from the Agency for Healthcare Research and Quality (AHRQ) to lead a statewide network of primary care providers, health systems, and academic centers to identify, develop, and implement patient-centered approaches to improve quality of care and outcomes for people with cardiovascular disease.

18 May 2021

Cancer patients without health insurance had significantly worse survival than Medicare beneficiaries

MUSC Hollings Cancer Center lung cancer researcher Gerard Silvestri, M.D., found that a lack of insurance leads to worse cancer survival than for those with Medicare, in a paper published in the May issue of Health Affairs.

17 May 2021

Study shows how Swedish people perceive information about COVID-19

Swedes' confidence in government officials varies greatly depending on their political leanings. Politicians are perceived as more in agreement when it comes to their views on how the corona pandemic is being handled in Sweden.

17 May 2021

Homicides surge in California amid Covid of schools shutdowns, youth programs

Amid a pandemic that left law enforcement agencies stretched thin and forced shutdowns that left young men with little to do, California registered a devastating surge in homicides in 2020 that hit especially hard in Black and Latino communities.

17 May 2021

Employment for frontline healthcare workers should be conditional on COVID-19 jab, argue ethicists

Employment for frontline healthcare workers should be conditional on COVID-19 vaccination, and unless they have a valid medical reason for not getting the jab, persistent refusniks should be temporarily redeployed to protect their colleagues and patients, argue ethicists in the Journal of Medical Ethics.

17 May 2021

Delaying second dose of covid-19 vaccine could result in lower mortality under certain conditions

Delaying the second dose of covid-19 vaccines, at least for people aged under 65, could result in up to 20% lower mortality, but only under certain conditions, finds a US study published by The BMJ today.

17 May 2021

A leading group of scientists working in universities, research centres, and innovative companies across Belgium, Germany, Greece, Portugal, Spain, and Switzerland just initiated a groundbreaking project hoping to treat stroke once and for all. The project, given the code name “ANGIE”, is backed by EU funding. "European scientists started developin

17 May 2021

Scientists initiate a groundbreaking project to treat stroke once and for all

A leading group of scientists working in universities, research centers, and innovative companies across Belgium, Germany, Greece, Portugal, Spain, and Switzerland just initiated a groundbreaking project hoping to treat stroke once and for all.

17 May 2021

Rivaroxaban reduces the occurrence of severe ischemic events in patients with peripheral artery disease

Rivaroxaban, in addition to low-dose aspirin, significantly reduced the occurrence of total severe events of the heart, limb or brain and issues related to other vascular complications in patients with symptomatic peripheral artery disease (PAD) who underwent lower extremity revascularization, a procedure to open blocked arteries in the leg.

17 May 2021

Education News and Research

Previous study has underestimated the true extent of racial disparities in COVID-19 deaths

Scientists develop experimental direct-acting antiviral therapy to treat COVID-19

Study provides new basis to compare the effectiveness of different tuberculosis treatments

Charles Fracchia selected for DARPA ISAT Study Group

COVID-19 pandemic causes disproportionate rise in cardiovascular deaths among racial, ethnic minorities

Around half of U.S. parents unwilling to vaccinate their children against COVID-19

Study: No major difference in mortality between patients treated with drug-coated and non-drug-coated devices

Type of heart failure may influence which approach is optimal for patients with AFib

Sotagliflozin reduces adverse cardiovascular events across patients with diabetes, heart failure

Pirfenidone significantly reduces a marker of heart muscle scarring

Omecamtiv mecarbil significantly reduces hospitalizations among patients with severe heart failure

Researchers receive $4.5 million grant to improve quality of care for people with cardiovascular disease

Cancer patients without health insurance had significantly worse survival than Medicare beneficiaries

Study shows how Swedish people perceive information about COVID-19

Homicides surge in California amid Covid of schools shutdowns, youth programs

Employment for frontline healthcare workers should be conditional on COVID-19 jab, argue ethicists

Delaying second dose of covid-19 vaccine could result in lower mortality under certain conditions

Scientists initiate a groundbreaking project to treat stroke once and for all

Rivaroxaban reduces the occurrence of severe ischemic events in patients with peripheral artery disease

New Approach Methodologies, the 3Rs and Multimodal Imaging in Preclinical Research - eBook eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics